Mutations of STK11 gene in NSCLC are associated with poor patient responses to ICIs, and mechanistically, this occurred because STK11 mutant NSCLCs lacked TCF1-expressing CD8 T cells, a phenotype recapitulated in human STK11 mutant NSCLCs. This evidence concerns the gene STK11 and non-small cell lung carcinoma.